Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,126 public trials 2,032 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Physician's Choice Chemotherapy in PD-(L)1-refractory, Relapsed or Refractory Classical Hodgkin Lymphoma (MK-4280A-008)

NCT05508867

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +8 more
Locations
  • The University of Arizona Cancer Center - North Campus ( Site 2216) Tucson, Arizona, United States
  • UCLA Hematology/Oncology - Santa Monica ( Site 2208) Los Angeles, California, United States
  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA-Hematology and Medical Oncology ( Site Torrance, California, United States
  • Moffitt Cancer Center ( Site 2200) Tampa, Florida, United States
View all 105 locations
View Trial Details
Completed

Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation

NCT01087294

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Hodgkin Disease, +15 more
Locations
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • National Marrow Donor Program Minneapolis, Minnesota, United States
View Trial Details
Completed

Study to Assess Effect of Oral Venetoclax Tablet in Combination With Oral Ibrutinib Capsule on Best Overall Response of Complete Response in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma

NCT04477486

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • NHO Nagoya Medical Center /ID# 221958 Nagoya, Aichi-ken, Japan
  • Aichi Cancer Center Hospital /ID# 221565 Nagoya, Aichi-ken, Japan
  • Kyushu University Hospital /ID# 223299 Fukuoka, Japan
  • Hokkaido University Hospital /ID# 221662 Sapporo, Hokkaido, Japan
View Trial Details
Completed

Non-invasive Diagnostics and Monitoring of MRD and Clonal Evolution in Waldenström's Macroglobulinemia and in IgM-MGUS

NCT03521596

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations
  • Divisione di Ematologia Ospedale Niguarda Milan, MI, Italy
  • SOS Ematologia Ospedale C. Massaia Asti, Italy
  • IRCCS Istituto Tumori Giovanni Paolo II - UOC Ematologia Bari, Italy
  • AOU Università degli Studi della Campania Luigi Vanvitelli Naples, Italy
View all 15 locations
View Trial Details
Completed

A Study of CPI-613 for Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lymphoma With High-Risk Translocations

NCT03793140

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +16 more
Locations
  • City of Hope Duarte, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
View Trial Details

Related conditions